Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house research & development (“R&D”) and manufacturing capabilities, today announced measures it is taking in response to the novel coronavirus pandemic (“COVID-19").
March 24, 2020
· 7 min read